asthma
asthma
11/15/2017
The FDA has approved a new add-on maintenance treatment option for patients with severe asthma with eosinophilic phenotype.
11/15/2017
asthma
asthma
11/15/2017
The FDA has approved a new add-on maintenance treatment option for patients with severe asthma with eosinophilic phenotype.
11/15/2017
asthma
asthma
11/15/2017
The FDA has approved a new add-on maintenance treatment option for patients with severe asthma with eosinophilic phenotype.
11/15/2017
Drug Therapy
Drug Therapy
11/14/2017
The US Food and Drug Administration recently approved the first pill with an embedded digital ingestion tracking system for patients with schizophrenia, bipolar disorder, and depression.
11/14/2017
FDA
FDA
11/13/2017
The US Food and Drug Administration has approved a once-daily oral antipsychotic for the maintenance treatment of schizophrenia.
11/13/2017
FDA
FDA
11/13/2017
The US Food and Drug Administration has approved a once-daily oral antipsychotic for the maintenance treatment of schizophrenia.
11/13/2017
FDA
FDA
11/13/2017
The US Food and Drug Administration has approved a once-daily oral antipsychotic for the maintenance treatment of schizophrenia.
11/13/2017
FDA
FDA
11/13/2017
The US Food and Drug Administration has approved the first new vaccine for hepatitis B virus in over 25 years in the United States.
11/13/2017
FDA
FDA
11/13/2017
The US Food and Drug Administration has approved the first new vaccine for hepatitis B virus in over 25 years in the United States.
11/13/2017
FDA
FDA
11/13/2017
The US Food and Drug Administration has approved the first new vaccine for hepatitis B virus in over 25 years in the United States.
11/13/2017